iBio, Inc. IBIO

Set alert

Price alert · IBIO

All alert types
0.82 USD +0.02 +2.81%

As of Nov 3, 2:51 PM ET

Bid
0.82 × 2
Ask
0.82 × 2
0.7902 Day range 0.8359
0.69 52-week range 3.82
YTD
-57.39%
1 year
-53.27%
Open
0.80
Prev close
0.7999
Mkt cap
40.86M
Vol
203.80K
Avg vol
704.61K
EPS
-0.32
P/E
0.00
Div yield
0.00%
More statistics
Low
0.7902
High
0.8359
Forward P/E
-1.44
Beta
0.00
Short ratio
1.92
Inst. own
31.49%
Dividend
0.00
Ex-div date
Earnings
Feb 14, 2025
50-d avg
2.60
200-d avg
2.17
1y target
3.60

3M chart

Chart tools
Interval

Signals (10)
NameDateAgo
MACD: Buy SignalOct 27, 20261 week ago
RSI: OversoldOct 22, 20261 week ago
RSI: OversoldOct 6, 20264 weeks ago
MACD: Sell SignalSep 28, 20261 month ago
MACD: Buy SignalSep 18, 20261 month ago
RSI: OversoldSep 15, 20261 month ago
MACD: Sell SignalAug 28, 20262 months ago
SMA: BearishAug 27, 20262 months ago
SMA: BearishAug 13, 20262 months ago
SMA: BullishAug 11, 20262 months ago

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 3.60
Ratings (0m) 1 1 buy · 0 hold · 0 sell
  • Strong buy0
  • Buy1
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 1
  • 1 month ago 2
  • 2 months ago 2
  • 3 months ago 2

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

IBIO analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.45-0.45 – -0.450.000.0%00.0%1
Next quarter-0.39-0.39 – -0.39-0.97899+60.2%00.0%1
Current year-1.74-1.74 – -1.74-4.29+59.5%0-100.0%1
Next year-2.05-2.05 – -2.05-1.74-17.8%00.0%1

Upgrades and downgrades

The latest rating changes

IBIO analyst upgrades and downgrades
DateFirmActionFromTo
Dec 17, 2024LUCID CAPITAL MARKETSInitiated—Buy
Jul 22, 2024Brookline CapitalInitiated—Buy
Jun 3, 2024Chardan CapitalMaintainedBuyBuy
May 28, 2024Chardan CapitalInitiated—Buy